University of Sydney receives $7.5 million grant for clinical trails

The University of Sydney has been successful in securing over $55 million in the latest round of National Health and Medical Research Council funding, including a $7.5 million grant for clinical trails, it was announced today.

The announcement was made by the Prime Minister at the University's Heart Research Institute. Also included in the funding announcement were six new Fellowships and 90 Project Grants which are worth $43.2 million in total.

A snapshot of some of the successful grants follows:

NHMRC Clinical Trials Centre: Professor John Simes and his team at the University of Sydney's NHMRC Clinical Trials Centre (CTC), has received a $7.5 million 'Clinical trials advances for better health outcomes' - Program Grant.

This major grant will allow the CTC to initiate major new clinical trails and a comprehensive program of research into trail methods, biostatistician analysis, health outcome analysis and decision analysis. Patient preferences and decision making, particularly in cancer, will be a major focus.

INTERACT: a randomised trial of intensive blood pressure lowering in acute intercerebral haemorrhage (ICH), led by Professor Craig Anderson from the University's George Institute for International Health, has received a $2.5 million project grant.

This international, multi-centre, randomised controlled trial, looking at the effectiveness of early, intensive blood pressure lowering in 2,000 patients with ICH. ICH is the most serious form of stroke affecting several thousand Australians and 2-3 million people throughout the world each year.

At present over 30 per cent of patients die early after onset ICH and at least half of the survivors are left permanently disabled. Evidence suggests that even modest elevations in blood pressure are associated with poor outcomes in ICH; therefore early BP lowering using routinely available agents, if shown to be effective, would provide a simple and widely applicable therapy.

Professor Anderson has also secured an NHMRC Research Fellowship in this round of funding.

Sydney Adolescent Vascular and Eye Study - SAVES: Professor Paul Mitchell from the Sydney Adolescent Vascular and Eye Study has received a Project Grant of over $1.2 million to look at retinal arteriolar narrowing, which is a strong predictor of hypertension and cardiovascular disease among adults.

The study will include a longitudinal vascular study examining the genesis of cardiovascular risk in childhood, and a longitudinal eye study that will examine the emergence of early myopic retinal changes and visual impairment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vitamin D may lower blood pressure in older people with obesity